IKT 股价走势图
IKT 股票价格预测
Inhibikase Therapeutics Inc
$2.35
0.85%
$0.02
收盘价：Jul 27, 16:00:00 GMT-4
$2.35
0%
$0
盘后：Jul 27, 17:21:14 GMT-4
返回
Inhibikase Therapeutics Inc (IKT) 股票价格预测
关键数据
前收盘价
$2.33
开盘价
$2.36
当日区间
$2.31 - $2.39
52周范围
$1.33 - $2.35
交易量
507.3K
平均成交量
1.0M
股息收益率
--
每股收益（TTM）
-1.15
市值
$310.2M
什么是 IKT？
Inhibikase Therapeutics, Inc. is a clinical-stage pharmaceutical company, which engages in development of protein kinase inhibitor therapeutics to modify the course of Parkinson's-related disorders and other diseases of the Abelson Tyrosine Kinases. The company is headquartered in Wilmington, Delaware and currently employs 35 full-time employees. The company went IPO on 2020-12-23. The firm is focused on developing Abelson Tyrosine Kinase inhibitor therapeutics for cardiopulmonary disease. The Company’s multi-therapeutic pipeline includes IKT-001, a prodrug of imatinib mesylate, for pulmonary arterial hypertension (PAH).
